Fast-track concordance studies with our reliable biomarker services and Health Institution status.
Decades of experience developing and validating companion diagnostics for leading biotech and pharma clients.
A technology agnostic approach to enable an unbiased selection of the most suitable platforms.
Specialty testing in CLIA-certified, CAP accredited, and GCLP compliant service laboratories to support concurrent clinical trials and regulatory submissions.
Global standardization and harmonization of IHC assays via our Biomarker Academy™ training programs and post-approval services.
One of the largest commercial fleets of proteomics, genomics, and molecular pathology instruments –
all under one roof and laboratories on different continents to speed testing.
We routinely conduct concordance testing using our diverse, platform agnostic capabilities spanning the following technologies.
Join Discovery Life Sciences at Phacilitate's Advanced Therapies Week 2025, Jan 20-23 in Dallas! Visit us at Booth 161 and join Dr. Yuki Maves' presentation on Jan 23. Supply Chain: […]
Join Discovery at Precision Medicine Tri-Con 2025.
Join Discovery at World CB & CDx Summit Europe 2025.
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing
